Jeffrey Donohue
Corporate Officer/Principal chez Novartis Institutes for Biomedical Research, Inc.
Profil
Jeffrey Donohue is currently working as a Corporate Counsel at Novartis Institutes for Biomedical Research, Inc. He previously worked as an Independent Non-Executive Director at Spectra Systems Corp.
from 2012 to 2016.
He has a graduate degree from Boston University and an undergraduate degree from Brandeis University.
Postes actifs de Jeffrey Donohue
Sociétés | Poste | Début |
---|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Anciens postes connus de Jeffrey Donohue
Sociétés | Poste | Fin |
---|---|---|
SPECTRA SYSTEMS CORPORATION | Directeur/Membre du Conseil | 31/05/2016 |
Formation de Jeffrey Donohue
Boston University | Graduate Degree |
Brandeis University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SPECTRA SYSTEMS CORPORATION | Electronic Technology |
Entreprise privées | 1 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |